Patents by Inventor Paul B. Benni
Paul B. Benni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12228507Abstract: A method and apparatus of non-invasively determining a blood circulatory hemoglobin value for a subject using a near-infrared spectrophotometric (NIRS) sensing device is provided. The method includes: a) non-invasively sensing tissue of the subject using the NIRS sensing device at about a time T1, and determining at least one NIRS tissue totalHb value; b) acquiring at least one circulatory blood sample from the subject at about the time T1; c) determining at least one blood circulatory THb value; d) calibrating the NIRS sensing device using the at least one blood circulatory THb value and the at least one MRS tissue TotalHb value; and e) determining at least one blood circulatory hemoglobin value using the calibrated NIRS sensing device and the at least one NIRS tissue totalHb value.Type: GrantFiled: August 19, 2022Date of Patent: February 18, 2025Assignee: Becton, Dickinson and CompanyInventor: Paul B. Benni
-
Publication number: 20250040844Abstract: A method and apparatus for monitoring a subject's autoregulation function state is provided. The method includes: a) continuously sensing a tissue region of the subject with a tissue oximeter, the sensing producing first signals, and determining frequency domain tissue oxygen parameter values; b) continuously measuring a blood pressure level of the subject using a blood pressure sensing device, the measuring producing second signals, and determining frequency domain blood pressure values; c) determining a coherence value indicative of the subject's autoregulation state in each of a plurality of different frequency bands; and d) determining a peak coherence value indicative of the subject's autoregulation state based on the determined coherence value from each of the plurality of different frequency bands.Type: ApplicationFiled: October 21, 2024Publication date: February 6, 2025Inventor: Paul B. Benni
-
Patent number: 12121352Abstract: A method and apparatus for monitoring a subject's autoregulation function state is provided. The method includes: a) continuously sensing a tissue region of the subject with a tissue oximeter, the sensing producing first signals, and determining frequency domain tissue oxygen parameter values; b) continuously measuring a blood pressure level of the subject using a blood pressure sensing device, the measuring producing second signals, and determining frequency domain blood pressure values; c) determining a coherence value indicative of the subject's autoregulation state in each of a plurality of different frequency bands; and d) determining a peak coherence value indicative of the subject's autoregulation state based on the determined coherence value from each of the plurality of different frequency bands.Type: GrantFiled: October 14, 2022Date of Patent: October 22, 2024Assignee: Edwards Lifesciences CorporationInventor: Paul B. Benni
-
Publication number: 20240156358Abstract: A method for providing autoregulation function information is provided. The method includes: a) continuously sensing a tissue region with a tissue oximeter during a period of time, the sensing producing first signals representative of at least one tissue oxygenation parameter; b) continuously measuring a blood pressure level during the period of time using a blood pressure sensing device, the measuring producing second signals representative of the blood pressure level of the subject; c) evaluating the at least one tissue oxygenation parameter using the first signals and the blood pressure level using the second signals, relative to one another; d) producing a recent profile of autoregulation data using the first and second signals from a recent portion of the period of time; e) producing a historical profile of autoregulation data using the first and second signals from a historical portion of the period of time.Type: ApplicationFiled: October 26, 2023Publication date: May 16, 2024Inventors: Paul B. Benni, Antonio Albanese, Anusha Alathur Rangarajan, Andres S. Aguirre, Brennan Michael Schneider
-
Publication number: 20240138724Abstract: A method of and system for non-invasively measuring tissue hemoglobin of a subject is provided. The method includes: a) non-invasively sensing tissue of a subject using a near infrared spectrophotometric (NIRS) sensing device, and determining at least one NIRS tissue THb value based on the non-invasive sensing; b) determining whether at least one Hb confounding factor is present during the non-invasive tissue sensing with the NIRS sensing device; and c) determining a NIRS circulatory THb portion of the NIRS tissue THb value based on the presence of the at least one Hb confounding factor during the non-invasive tissue sensing with the NIRS sensing device.Type: ApplicationFiled: January 2, 2024Publication date: May 2, 2024Inventors: Paul B. Benni, Andres S. Aguirre, Antonio Albanese
-
Publication number: 20240081721Abstract: A method and apparatus for determining a subject's autoregulation function state is provided. The method includes: continuously sensing a tissue region of a subject with a tissue oximeter to produce first signals representative of at least one tissue oxygenation parameter during a period of time; continuously measuring a blood pressure level of the subject during the period of time to produce second signals representative of the subject's blood pressure during the period of time; determining a presence of a confounding factor that affects the sensed tissue oxygenation parameter in a manner independent of an autoregulation function of the subject, the determination using the first signals; using the first and second signals to determine an autoregulation function state of the subject when the absence of the confounding factor is determined. The method may include determining an at least one of an LLA or a ULA of a subject's autoregulation function state.Type: ApplicationFiled: November 17, 2023Publication date: March 14, 2024Inventors: Paul B. Benni, Zhongping Jian, Antonio Albanese, Andres S. Aguirre, Brennan Michael Schneider, Anusha Alathur Rangarajan
-
Publication number: 20240049996Abstract: A method and apparatus for non-invasively determining a tissue arterial oxygen saturation value of a tissue body is provided. The method includes: a) transmitting at least a first wavelength and a second wavelength of near-infrared light into a tissue body, the first wavelength different from the second wavelength; b) sensing the tissue body for the near-infrared light, and producing signals representative of the sensed near-infrared light; c) determining an AC component of a first tissue oxygen parameter using the signals; d) determining an AC component of a second tissue oxygen parameter using the signals; and e) determining a tissue arterial oxygen saturation value of a tissue body using the determined AC component of the first tissue oxygen parameter and the determined AC component of the second tissue oxygen parameter.Type: ApplicationFiled: October 20, 2023Publication date: February 15, 2024Inventor: Paul B. Benni
-
Publication number: 20230114463Abstract: A method and apparatus for monitoring a subject's autoregulation function state is provided. The method includes: a) continuously sensing a tissue region of the subject with a tissue oximeter, the sensing producing first signals, and determining frequency domain tissue oxygen parameter values; b) continuously measuring a blood pressure level of the subject using a blood pressure sensing device, the measuring producing second signals, and determining frequency domain blood pressure values; c) determining a coherence value indicative of the subject's autoregulation state in each of a plurality of different frequency bands; and d) determining a peak coherence value indicative of the subject's autoregulation state based on the determined coherence value from each of the plurality of different frequency bands.Type: ApplicationFiled: October 14, 2022Publication date: April 13, 2023Inventor: Paul B. Benni
-
Publication number: 20220412883Abstract: A method and apparatus of non-invasively determining a blood circulatory hemoglobin value for a subject using a near-infrared spectrophotometric (NIRS) sensing device is provided. The method includes: a) non-invasively sensing tissue of the subject using the NIRS sensing device at about a time T1, and determining at least one NIRS tissue totalHb value; b) acquiring at least one circulatory blood sample from the subject at about the time T1; c) determining at least one blood circulatory THb value; d) calibrating the NIRS sensing device using the at least one blood circulatory THb value and the at least one MRS tissue TotalHb value; and e) determining at least one blood circulatory hemoglobin value using the calibrated NIRS sensing device and the at least one NIRS tissue totalHb value.Type: ApplicationFiled: August 19, 2022Publication date: December 29, 2022Inventor: Paul B. Benni
-
Patent number: 11478171Abstract: A method and apparatus for monitoring a subject's autoregulation function state is provided. The method includes: a) continuously sensing a tissue region of the subject with a tissue oximeter, the sensing producing first signals, and determining frequency domain tissue oxygen parameter values; b) continuously measuring a blood pressure level of the subject using a blood pressure sensing device, the measuring producing second signals, and determining frequency domain blood pressure values; c) determining a coherence value indicative of the subject's autoregulation state in each of a plurality of different frequency bands; and d) determining a peak coherence value indicative of the subject's autoregulation state based on the determined coherence value from each of the plurality of different frequency bands.Type: GrantFiled: December 20, 2018Date of Patent: October 25, 2022Assignee: Edwards Lifesciences CorporationInventor: Paul B. Benni
-
Patent number: 11454589Abstract: A method and apparatus of non-invasively determining a blood circulatory hemoglobin value for a subject using a near-infrared spectrophotometric (NIRS) sensing device is provided. The method includes: a) non-invasively sensing tissue of the subject using the NIRS sensing device at about a time T1, and determining at least one NIRS tissue totalHb value; b) acquiring at least one circulatory blood sample from the subject at about the time T1; c) determining at least one blood circulatory THb value; d) calibrating the NIRS sensing device using the at least one blood circulatory THb value and the at least one NIRS tissue TotalHb value; and e) determining at least one blood circulatory hemoglobin value using the calibrated NIRS sensing device and the at least one NIRS tissue totalHb value.Type: GrantFiled: October 4, 2019Date of Patent: September 27, 2022Assignee: Edwards Lifesciences CorporationInventor: Paul B. Benni
-
Patent number: 11363976Abstract: A method and apparatus for non-invasively determining a blood oxygen saturation level within tissue of an internal organ is provided. The method includes: applying a near infrared spectrophotometric sensor on an external surface of an organ; operating the sensor to emit light from a light source directly into the tissue of the organ at a first tissue location, and to sense the emitted light at a second tissue location, which emitted light has traveled through the tissue between the first and second tissue locations, and to produce signals representative of the intensity of the sensed emitted light; using a processor to execute instructions, which instructions cause the processor to: determine an attenuation value of the emitted light for each wavelength, and determine a blood oxygen saturation level of the organ tissue using the determined attenuation values for each of the plurality of wavelengths.Type: GrantFiled: November 22, 2019Date of Patent: June 21, 2022Assignee: Edwards Lifesciences CorporationInventor: Paul B. Benni
-
Patent number: 10918321Abstract: An apparatus and method for non-invasively determining a blood oxygen parameter value of a subject's tissue is provided. An embodiment of the method includes the steps of: a) providing a spectrophotometric sensor that includes a processing portion and a transducer, b) detecting at least a portion of transmitted light after passage through the subject's tissue and producing initial signal data from the detected light; and c) using the processing portion to: (i) determine a value representative of an attenuation of at least one wavelength of light detected; (ii) determine whether the representative attenuation value is outside a predefined range of attenuation values; and (iii) determine the blood oxygen parameter value using a first interrogation or an alternate interrogation setting.Type: GrantFiled: December 18, 2017Date of Patent: February 16, 2021Assignee: Edwards Lifesciences CorporationInventor: Paul B. Benni
-
Publication number: 20200383616Abstract: A method and apparatus for monitoring a subject's autoregulation function state is provided. The method includes: a) continuously sensing a tissue region of the subject with a tissue oximeter, the sensing producing first signals, and determining frequency domain tissue oxygen parameter values; b) continuously measuring a blood pressure level of the subject using a blood pressure sensing device, the measuring producing second signals, and determining frequency domain blood pressure values; c) determining a coherence value indicative of the subject's autoregulation state in each of a plurality of different frequency bands; and d) determining a peak coherence value indicative of the subject's autoregulation state based on the determined coherence value from each of the plurality of different frequency bands.Type: ApplicationFiled: December 20, 2018Publication date: December 10, 2020Inventor: Paul B. Benni
-
Publication number: 20200085359Abstract: A method and apparatus for non-invasively determining a blood oxygen saturation level within tissue of an internal organ is provided. The method includes: applying a near infrared spectrophotometric sensor on an external surface of an organ; operating the sensor to emit light from a light source directly into the tissue of the organ at a first tissue location, and to sense the emitted light at a second tissue location, which emitted light has traveled through the tissue between the first and second tissue locations, and to produce signals representative of the intensity of the sensed emitted light; using a processor to execute instructions, which instructions cause the processor to: determine an attenuation value of the emitted light for each wavelength, and determine a blood oxygen saturation level of the organ tissue using the determined attenuation values for each of the plurality of wavelengths.Type: ApplicationFiled: November 22, 2019Publication date: March 19, 2020Applicant: EDWARDS LIFESCIENCES CORPORATIONInventor: Paul B. Benni
-
Publication number: 20200033258Abstract: A method and apparatus of non-invasively determining a blood circulatory hemoglobin value for a subject using a near-infrared spectrophotometric (NIRS) sensing device is provided. The method includes: a) non-invasively sensing tissue of the subject using the NIRS sensing device at about a time T1, and determining at least one NIRS tissue totalHb value; b) acquiring at least one circulatory blood sample from the subject at about the time T1; c) determining at least one blood circulatory THb value; d) calibrating the NIRS sensing device using the at least one blood circulatory THb value and the at least one NIRS tissue TotalHb value; and e) determining at least one blood circulatory hemoglobin value using the calibrated NIRS sensing device and the at least one NIRS tissue totalHb value.Type: ApplicationFiled: October 4, 2019Publication date: January 30, 2020Inventor: Paul B. Benni
-
Patent number: 10485462Abstract: A method and apparatus for non-invasively determining a blood oxygen saturation level within an organ of a subject using direct application of a near infrared spectrophotometric sensor is provided. The method includes the steps of: a) transmitting a light signal directly into the subject's organ using the sensor; b) sensing a first intensity of the light signal and a second intensity of the light signal, after the light signal travels a predetermined distance through the organ of the subject; c) determining an attenuation of the light signal along multiple different wavelengths using the sensed first intensity and sensed second intensity; d) determining a difference in attenuation of the light signal between wavelengths; and e) determining the blood oxygen saturation level within the subject's organ using the difference in attenuation between wavelengths.Type: GrantFiled: June 3, 2016Date of Patent: November 26, 2019Assignee: EDWARDS LIFESCIENCES CORPORATIONInventor: Paul B. Benni
-
Patent number: 10117610Abstract: According to the present invention, a method and apparatus for non-invasively determining the blood oxygen saturation level within a subject's tissue is provided. The method comprises the steps of: a) providing a spectrophotometric sensor operable to transmit light into the subject's tissue, and to sense the light; b) detecting light after passage through the subject's tissue using the sensor, and producing initial signal data from the light sensed; c) calibrating the sensor to that particular subject using the initial signal data, thereby accounting for the specific physical characteristics of the particular subject's tissue being sensed; and d) using the calibrated sensor to determine the blood oxygen parameter value within the subject's tissue.Type: GrantFiled: October 3, 2016Date of Patent: November 6, 2018Assignee: CAS Medical Systems, Inc.Inventor: Paul B. Benni
-
Publication number: 20180192928Abstract: An apparatus and method for non-invasively determining a blood oxygen parameter value of a subject's tissue is provided. An embodiment of the method includes the steps of: a) providing a spectrophotometric sensor that includes a processing portion and a transducer, b) detecting at least a portion of transmitted light after passage through the subject's tissue and producing initial signal data from the detected light; and c) using the processing portion to: (i) determine a value representative of an attenuation of at least one wavelength of light detected; (ii) determine whether the representative attenuation value is outside a predefined range of attenuation values; and (iii) determine the blood oxygen parameter value using a first interrogation or an alternate interrogation setting.Type: ApplicationFiled: December 18, 2017Publication date: July 12, 2018Inventor: Paul B. Benni
-
Patent number: 9913601Abstract: A method and apparatus for monitoring a blood oxygen saturation level within a subject's tissue is provided. The method includes the steps of: a) sensing the subject's tissue using a near infrared spectrophotometric oximeter, and producing a value representative of the oxygen saturation level within the sensed tissue; b) comparing the determined saturation value to a predetermined threshold oxygen saturation value; and c) determining at least one of a time under threshold (TUT) value or an area under threshold (AUT) value using the determined saturation value and the threshold value.Type: GrantFiled: February 4, 2013Date of Patent: March 13, 2018Assignee: CAS Medical Systems, Inc.Inventor: Paul B. Benni